Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RMPL Pharma is an India-based pharmaceutical merchant exporter and wholesale distributor focused on oncology and other specialized medicines. The company appears to operate primarily as a commercial trading and distribution business rather than a drug developer, supplying original brands, generics, cold-chain products, biologics, biosimilars, vaccines, and nutraceutical products. RMPL Pharma markets products under its own brands including CANCare for oncology and BioHealth for food supplements and skin care. The company is part of the Royal Group of companies and serves customers in India as well as export markets across Africa, the Gulf, Europe, and Southeast Asia. Publicly available information suggests a broad commercial catalog rather than a disclosed proprietary clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RMPL Pharma.